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A B S T R A C T
Interleukin-7 (IL-7) is a central regulator of T cell survival and homeostasis and its expression is
indicative for naı¨ve and memory T cells. We cloned chicken IL-7Ra (CHIL-7Ra) and determined its
expression proﬁle in chicken lymphocyte subpopulations. The predicted protein sequence contained 460
amino acids. The extracellular domain exhibited features typical of a type I cytokine receptor; a
ﬁbronectin type III domain and the GXWSXWS motif were conserved. ChIL-7Ra mRNA is highly
expressed in lymphoid organs and in CD4+, CD8a+ and CD8b+ cells. A monoclonal antibody was
generated and expression of the protein investigated. ChIL-7Rawas expressed on CD4+ and CD8a+, but
not CD8b+, T cells, in contrast to the high mRNA expression levels in all of these cells. Upon polyclonal
stimulation with ConA, IL-7Ra was rapidly down-regulated on T cells, suggesting that in the chicken
expression of this receptor might also be correlated to the T cell activation status.
 2009 Elsevier Ltd. All rights reserved.
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Mammalian interleukin-7 (IL-7) is a cytokine involved in the
regulation of lymphopoiesis, acting primarily on cells of the
lymphoid lineage. IL-7 was originally deﬁned by its ability to
stimulate the proliferation of pre-B cells. Cells of the T cell lineage
also respond to IL-7; both foetal and adult thymocytes of all surface
phenotypes proliferate in response to IL-7 [1,2].
More recently it has become evident that IL-7 is a prototypic
homeostatic cytokine, produced constitutively by non-lymphoid
cells [3]. The mammalian IL-7 receptor (IL-7R) is composed of two
chains: the IL-7Ra-chain (CD127) and a common g-chain (gc or
CD132), shared by the receptors for IL-2, IL-4, IL-7, IL-9, IL-15 and
IL-21. IL-7Ra belongs to the type I cytokine receptor family.
Structurally, two ﬁbronectin-type III (FN) domains, four conserved
cysteine residues and a WS motif in the extracellular domains
characterise these receptors. The mature form of murine IL-7Ra
consists of 439 amino acids (aa) and is a membrane glycoprotein
with a single 25 aa transmembrane domain. The 195 aa
cytoplasmic tail contains partially characterised regions; one
region (A) that is rich in acidic residues, and one region (T) that
contains three tyrosine residues that are conserved in mouse and
man (Y401, Y449, and Y456 as numbered in the murine sequence).Abbreviations: IL, interleukin; chIL-7Ra, chicken interleukin-7 receptor alpha chain.
* Corresponding author. Tel.: +31 30 2531872; fax: +31 30 2533555.
E-mail address: L.Vervelde@uu.nl (L. Vervelde).
0145-305X/$ – see front matter  2009 Elsevier Ltd. All rights reserved.
doi:10.1016/j.dci.2009.05.001In addition, a small membrane-proximal domain termed ‘‘Box 1’’ is
conserved throughout the class I cytokine receptor family [4].
Whereas the gc is expressed on most haematopoietic cells, IL-
7Ra is almost exclusively expressed on cells of the lymphoid
lineage in which it has crucial functions (reviewed in [3,5]). IL-7
has emerged as a key cytokine involved in controlling the survival
of peripheral resting T cells and their homeostatic turnover. The
effect of IL-7 on T cells is controlled by the expression of the IL-7R,
the state of differentiation of the cell, the availability of the
cytokine and whether there is concomitant T cell receptor
signalling (reviewed in [3,5]). Expression of IL-7Ra is a marker
of naı¨ve and memory T cells and it may serve to distinguish
memory from effector T lymphocytes at early phases of the
immune response [5–7], especially when combined with the
expression of CD62L. Cell subsets described as central memory T
cells (CD127hi and CD62Lhi) and peripheral effectormemory T cells
(CD127hi and CD62Llo) can be distinguished.
Moreover, surface expression of CD127 (IL-7Ra) combinedwith
CD25 (IL-2Ra) can differentiate between human regulatory and
conventional CD4+ T cells in adult peripheral blood [8]. CD127lo T
regulatory cells and CD127hi conventional T cells can be
distinguished within the CD25+ CD45RO+RA effector/memory
and CD25+ CD45RA+RO naı¨ve compartments. CD25+CD127lo
cells have suppressive activity in vitro whereas CD25+ CD127hi
cells do not [8].
For the class I cytokine receptor family in the chicken, all of the
common signalling chains have either been cloned and char-
acterised [9,10] or are present in the chicken genome sequence
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expressed [12]. In the chicken, naı¨ve, effector and memory T cells
cannot be distinguished yet and the presence of regulatory T cells
has not been demonstrated, but tools and assays to dissect T cell
subsets are becoming available [13]. Here, we describe the cloning
and expression of the chIL-7Ra and the development of a
monoclonal antibody speciﬁc for chIL-7Ra, which will facilitate
future research in chicken T cell development and discrimination
between functional T cell subsets.
2. Materials and methods
2.1. Animals and tissues
To study mRNA expression of IL-7Ra, liver, spleen, thymus,
bursa of Fabricius and bone marrow were collected from broiler
chickens (Ross) at embryonic days 7 and 20 (ED7 and ED20; n = 4).
Peripheral blood and spleens from 4-day-old to 6-week-old broiler
chickens were used to sort cell subpopulations. Peripheral blood
leukocytes (PBL) were isolated by density gradient centrifugation
for 20 min at 850  g using FICOLL-Hypaque 1.078. Subpopula-
tions of leukocyteswere obtained after staining of cellswithmouse
anti-chicken CD4-PE (CT-4), CD8a-FITC (CT-8), CD8b-PE (EP42),
and Bu-1-FITC (ChB6 clone AV20; Southern Biotechnology (SB),
USA). Cells were sorted using a FACS Vantage SE instrument
(Becton Dickinson). For every cell subpopulation at least 3  104
PBL and 1  106 splenocytes were analysed. For total RNA
extractions, organs and cells were immediately immersed in
RNAlater (Ambion) and stored at 20 8C until RNA was extracted.
2.2. Isolation of chicken IL-7Ra cDNA
Total RNAwas extracted in the presence of buffer containingb-
mercaptoethanol and guanidine using an RNeasyMini Kit (Qiagen)
following themanufacturer’s instructions. RNAwas eluted in 30 ml
RNase-free water and stored at 20 8C until required. The
extracted RNA was reverse-transcribed using an iScript cDNA
Synthesis Kit (Bio-Rad), with an oligo dT primer. CHIL-7Ra was
ampliﬁed using Kod Hot Start DNA Polymerase (Novagene)
according to the manufacturer’s protocol. Brieﬂy, cDNA (1 ml)
was mixed with 200 mM dNTPs, 1 PCR buffer for Kod Hot Start
DNA Polymerase, forward and reverse primers (0.3 mM) and 1 unit
Kod Hot Start DNA Polymerase in 50 ml ﬁnal volume. PCR
conditions were as follows, 1 cycle of 94 8C for 5 min followed
by 30 cycles of 94 8C for 15 s, 61 8C for 30 s and 72 8C for 20 s
followed by 1 cycle at 72 8C for 5 min, using an iCycler (Bio-Rad).
All primers used for the PCR were designed to the EST sequence of
chIL-7Ra in the chicken genome. Two primers, chIL-7R forward
(50-AGTATAAAGTCAGTGAGTGAGGGTTTC-30) and chIL-7R reverse
(50-AATAGAGAGCTTCAGTATCCAGCTTG-30) were designed outside
the predicted chIL-7Ra coding sequence. To increase speciﬁcity of
the PCR the ﬁrst PCR product was used for a nested PCR. To obtain
the full-length cDNA sequences for chIL-7Ra, two primers, chIL-
7R-nested forward (50-GGGGAATTCAGCATGCTCAGAATGACACG-
30) and chIL-7R-nested reverse (50-GGGTCTAGAAACGCCTACT-Table 1
Real-time qRT-PCR probes and primers.
RNA target Probe/primer sequence (50-30)
IL-7Ra Probe (FAM)-TCGT
F ATTCTGGGA
R CTTACACAG
28S Probe (VIC)-AGGAC
F GGCGAAGCC
R GACGACCGAGATTTTTGTAAAAGC-30) were used in PCR. The forward primer
contains an EcoRI restriction site at the 50-end and the reverse
primer contains a XbaI restriction site at the 30-end. These
restriction sites were used to ligate the PCR product into pCI-neo
(Promega) and pcDNA3.1 myc-his (Invitrogen). Library-competent
Escherichia coli DH5a cells (Invitrogen) were transfected with the
plasmids using FuGene-6 Transfection Reagent (Roche) according
to the manufacturer’s protocol. Plasmid DNA was extracted with a
Quantum Prep Plasmid Maxiprep Kit (Bio-Rad). The insert DNA
was sequenced using the primers T7 promoter (50-TAATACGACT-
CACTATAGGG-30) and BGH-Reverse (50-TAGAAGGCACAGTCGAGG-
30) for pcDNA3.1 myc-his and T7EEV (50-AAGGCTAGAGTACTTAA-
TACGA-30) and T3 (50-ATTAACCCTCACTAAAGGGA-30) for pCI-neo.
Alignment of various IL-7Ra aa sequences was performed using
the ClustalW Chicken FN_III domain prediction was performed
using Pfam (http://www.sanger.ac.uk/software.pfam/). The
growth factor and cytokine receptors family signature 2 (GFCRFS2)
motif was predicted by Prosite motif search (http://www.expa-
sy.ch/prosite). Similarity searches were performed using Blast
Alignment (NCBI: http://www.ncbi.nlm.nig.gov/).
2.3. Chicken IL-7Ra expression analysis by real-time quantitative RT-
PCR
IL-7RamRNA levels in different organs and cell subpopulations
were quantiﬁed using real-time quantitative RT-PCR (qRT-PCR).
For both cytokine receptor- (Accession No. EF116487) and 28S
rRNA-speciﬁc ampliﬁcation, primers and probes were designed
using the Primer Express software program (PE Applied Biosys-
tems). Details of probes and primers are given in Table 1.
QRT-PCR was performed using the TaqMan Universal PCR
Master Mix (PE Applied Biosystems). Ampliﬁcation and detection
of speciﬁc products were performed using the ABI PRISM 7700
Sequence Detection System (PE Applied Biosystems) with the
following ampliﬁcation proﬁle: 1 cycle of 50 8C for 2 min, 95 8C for
10 min and 40 cycles of 95 8C for 20 s, 59 8C for 1 min. Primerswere
used at 600 nM and probes at 100 nM. Quantiﬁcationwas based on
the increased ﬂuorescence detected by the ABI-PRISM 7700
Sequence Detection System due to hydrolysis of the target-speciﬁc
probes by the 50 nuclease activity of the AmpliTaq Gold DNA
Polymerase during PCR ampliﬁcation. A passive reference dye ROX
(present in the TaqMan Universal PCR Master Mix), which is not
involved in ampliﬁcation, was used to correct for ﬂuorescent
ﬂuctuations resulting from changes in the reaction conditions, for
normalisation of the reporter signal.
Results are expressed in terms of the threshold cycle value (Ct),
the cycle at which the change in reporter dye passes the
signiﬁcance threshold (DRn). Corrections for variations in RNA
preparation and sampling were performed according to Elda-
ghayes et al. [14]. Results were then expressed as 40-Ct.
2.4. Expression chIL-7Ra on leukocytes
Two Balb/c mice were immunised three times with 50 mg
plasmid DNA, pCI-neo-chIL-7Ra, at three-week intervals. AfterAccession No.
GTGGCCAAACCTTCCTGATCAT-(TAMRA) EF116487
AAGCAGGATCAAG
TCGCTCCAGAGTTATTT
CGCTACGGACCTCCACCA-(TAMRA) X59733
AGAGGAAACT
TTTGCACGTC
Fig. 1. Nucleotide sequence and predicted amino acid sequences of chicken IL-7Ra Different font colours indicate the different exons.
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Hybridomaswere generated by fusion of splenic lymphocytes, two
weeks after the last boost, with mouse myeloma Sp2/0–Ag14 cells,
according to the method of Segers et al. [15]. After fusion, the cells
were distributed in ﬂat-bottomed 96-well plates. Supernatants
from wells containing growing colonies were tested by indirect
immunoﬂuorescence on chicken PBL and measured by ﬂow
cytometry. The second round of selection also included reactivity
on spleen cryosections using immunohistochemistry [16] and onFig. 2. Comparison of amino acid sequences between chicken IL-7Ra and human, m
EDL03312, XP_855408, XP_599818 and NP_001106979 respectively). The predicted Fn
receptors family signature 2) domain (GXWSXWSmotif) in the Fn_III domain is overlined
cytoplasmic tail, a small membrane-proximal domain, termed ‘‘Box 1’’ (Val277 to His284) i
protein, containing two tyrosine residues (Tyr450 and Tyr457), is double-overlined.COS cells expressing recombinant chIL-7Ra. Positive wells were
cloned by single cell limiting dilution on the FACSVantage cell
sorter (BD Biosciences, San Jose, CA) using CellQuest software (BD
Biosciences). Immunoglobulin subclass was determined using a
Beadlyte Mouse Immunoglobulin Isotyping Kit (Upstate) using the
Luminex 100 System.
IL-7Ra expression at the protein levelwasmeasured on PBL and
splenocytes from Heisdorf & Nelson Silver Nick layer birds of one,
three and six weeks of age. Blood was diluted in pre-warmedouse, dog, cow and zebraﬁsh IL-7Ra (Accession numbers EF116487, NP_002176,
_III domain is underlined. The conserved GFCRFS2 (growth factors and cytokine
and annotated. The predicted trans-membrane domain is double-underlined. In the
s also overlined and annotated. A conserved 11 aamotif at the COOH-terminal of the
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spin centrifugation (62  g, 20 min, RT). PBL and splenocytes were
triple-stained with mouse anti-chicken IL-7Ra and goat anti-
mouse (IgM)-APC (SB), ﬂuorescein (FITC)-labeled or phycoerythrin
(PE)-labeled mouse anti-chicken CD8a, CD8b, CD4, ChB6 (Bu-1-
FITC), or KUL01-FITC (monocyte/macrophages; SB) and with T cell
receptor-speciﬁc antibodies TCR-gd-FITC (TCR1), TCR-ab1-FITC
(TCR2), or TCR-ab2-FITC (TCR3; SB). Cells were acquired on a
FACSCalibur ﬂow cytometer (BD Biosciences) and analysed using
CellQuest software.
Splenocytes were stimulated for 24 h at 41 8C with 5 or 10 mg/
ml ConA or medium (RPMI-1640, 5% FCS, penicillin, streptomycin)
and triple-stained for chIL-7Ra and T cell markers as described
above.
Immunocytochemical stainings were performed on cryosec-
tions of spleen and thymus. Sections were acetone ﬁxed and
incubated with monoclonal antibodies speciﬁc for chIL-7Ra
(biotin labeled) and ChB6 (Bu-1), CD4, CD8a, CD8b, TCR-ab1, TCR-
ab2, TCR-gd or KUL01 (monocytes andmacrophages). Slides were
washed and incubated with avidin–enzyme complex (Vectastain1
Elite ABC kit) and goat anti-mouse IgG–AP. Alkaline phosphatase
activity was developed with Fast Blue BB salt and then the
peroxidase activity was developed with AEC [17].
3. Results
3.1. Cloning and characterisation of full length chIL-7Ra
Using a PCR-based approach with primers designed to the
predicted sequence in the chicken genome, we cloned the CHIL-
7Ra chain cDNA (Fig. 1). The predicted protein sequence of chIL-
7Ra contained 460 aa residues (Fig. 1), and included a predictedFig. 3. A. Quantiﬁcation of chIL-7RamRNA extracted from lymphoid and non-lymphoid
values +SD of 4 birds per time-point. B. PBL and splenocyte subpopulations were sor
subpopulations were quantiﬁed. Results are expressed as the mean corrected 40-Ct vacleavable signal peptide (Met1 to Gly23), and a calculated
molecular mass of 52.2 kDa. The predicted aa sequence of chIL-
7Ra was compared with those of human, mouse, rat, dog,
tetraodon and fugu (Fig. 2). Three cysteine residues and the
GXWSXWS motif (aa 220–226) located in the ﬁbronectin type III
domain (Pro134 to Ser223) were conserved in all species. Another
four cysteine residues were conserved with mammalian species,
except the dog, where only two were conserved. ChIL-7Ra showed
34.4% identity to human IL-7Ra at the aa level. The predicted
transmembrane domain was 24 aa in length, from Val247 to Glu270.
The cytoplasmic tail contains regions that are partially charac-
terised in human andmouse. A smallmembrane-proximal domain,
termed ‘‘Box 1’’ (Val277 to His284), was highly conserved. An 11 aa
motif at the COOH-terminal of the protein, containing two tyrosine
residues (Tyr450 and Tyr457), was completely conserved between
the chicken and mammalian species. Four potential N-linked
glycosylation sites (NXS/T) were located at aa 64–66, 74–76, 141–
143, and 362–364 in chIL-7Ra, compared to nine in human IL-7Ra.
3.2. Expression of chIL-7Ra mRNA
Quantiﬁcation of RNA levels was performed using real-time
qRT-PCR and normalised against 28S rRNA expression levels.
Expression of chIL-7Ra mRNA was analysed in organs of ED20
embryos and in chickens post-hatch (Fig. 3A). In both embryos and
chickens post-hatch, expression was seen in all organs, with
highest levels of chIL-7Ra mRNA detected in lymphoid organs
which contain a high number of T cells. Expression of chIL-7R
mRNAwas detected as early as ED7 in pooled lymphoid organs and
in the yolk sac, though expression levels were lower than at ED20
(data not shown). Lymphocyte subpopulations from blood and
spleen of 6-week-old birds were sorted and analysed (Fig. 3B). Inorgans of birds of different ages. Results are expressed as the mean corrected 40-Ct
ted using a FACSVantage and chIL-7Ra mRNA expression levels in the different
lues +SD of at least 3 chickens.
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chickens and signiﬁcantly higher expression of chIL-7Ra mRNA
was found in T cells compared to B cells (p < 0.05).
3.3. Expression of chIL-7Ra on leukocytes
After several rounds of selection, one hybridoma (8F10E11)was
selected that reacted with PBL using ﬂow cytometry, on cryosec-
tions of spleen using immunohistochemistry, and on transfected
COS cells. This clone was found to be secreting an IgM antibody
with a kappa light chain and was used for further characterisation
and expression of chIL-7Ra on leukocytes.
Age-related expression of chIL-7Ra was determined on PBMC
and splenocytes of birds of one, three and six weeks of age.
Although chB6+ B cells expressed chIL-7Ra at the mRNA level, the
percentage of chB6+ B cells that expressed the protein at the
membrane surface was very low (<1%; data not shown). On
monocytes and macrophages (KUL01+ cells), chIL-7Ra expression
was also rare (<1%; data not shown). No changes with age in blood
and spleen were found for either cell population.
T cells were triple-stained for chIL-7Ra; CD4, CD8a or CD8b;
and T cell receptors (Fig. 4A). In peripheral blood, 90% of the CD4+Fig. 4. A. Expression of chIL-7Ra on PBL and splenocytes of 1-, 3- or 6-week-old birds, as
that express chIL-7Ra. Grey bars show the percentages of CD4+ IL-7Ra+ or CD8a+ IL-7Ra
represent percentage positive cells within the live cell gate +SD (n = 4). B. Expression of c
CD8a, and CD8b and FACS analysis indicated that CD8aint cells (circled) are CD8b- ancells expressed chIL-7Ra of which 70–75% were TCR-ab1+ (TCR2)
and 25–30% TCR-ab2+ (TCR3). In the spleen, 70–80% of the CD4+
cells expressed chIL-7Ra, with a similar distribution of the TCRs as
on CD4+ cells in blood. ChIL-7Rawas not preferentially expressed
on TCR-ab1+ or on TCR-ab2+ cells. The percentage of CD4+ cells
that expressed chIL-7Ra in both blood and spleen was not
signiﬁcantly affected by age.
In peripheral blood, the percentage of CD8a+ cells expressing
chIL-7Radecreasedwithage from60%to30%.Of theCD8a+ IL-7Ra+
cells in blood, 75% of cells co-expressed TCR-ab1 and 25%TCR-ab2,
withno signiﬁcant changeswith age. Fewer than1%of the cellswere
TCR-gd+ (data not shown). In the spleen the percentage of CD8a+
cells that expressed chIL-7Ra was much lower than in blood, but a
similar decreasewith agewas found, ranging from30% to 10%.With
age thepercentage ofCD8a+ chIL-7Ra+ cells that co-expressedTCR-
ab1 decreased whereas the percentage of cells that co-expressed
TCR-ab2 increased. The percentage of CD8a+ chIL-7Ra+ TCR-gd+
cellswashigher in the spleen than in theblood, increasing from1%to
10% with age (data not shown).
CD8a expression could be subdivided into high and inter-
mediate expression (Fig. 4B). The expression of chIL-7Ra in blood
and spleenwasmostly conﬁned to the CD8aint cells. These CD8aintmeasured by FACS analysis. Black bars show the percentage of T cells (CD4 or CD8a)
+ cells that express TCR-ab1 (TCR2; white bars) or TCR-ab2 (TCR3; grey bars). Bars
hIL-7Ra on CD8a+ PBL. Cells of a 3-week-old bird were triple-stained for chIL-7Ra,
d chIL-7Ra+, whereas CD8ahi cells co-express CD8b but rarely chIL-7Ra.
Fig. 5. Splenocytes of 3-week-old birds (n = 4) were stimulated with 5 or 10mg/ml
ConA for 24 h. The cells were double-stained for expression of chIL-7Ra and the T
cell markers CD4 or CD8a. ChIL-7Ra expression levels are given as geometric mean
ﬂuorescent intensity (geometric MFI) +SD.
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expression of chIL-7Ra at the mRNA level. Changing the order in
which the monoclonal antibodies were used to stain the cells did
not affect the result, suggesting that the lack of staining of CD8b+
cells was not due to steric hindrance of the monoclonal antibodies
that were used.
Splenocytes were stimulated with a polyclonal T cell stimulus,
ConA, in order to study changes in expression of chIL-7Ra upon
activation. Stimulation for 24 h resulted in a tremendous down-
regulation of chIL7Ra on CD4+ and only a slight down-regulation
on CD8a+ T cells (Fig. 5). The number of CD4+ and CD8a+ cells
increased after stimulation and the geometric MFI of CD4+ and
CD8a+ cells slightly decreased (data not shown).
The expression of chIL-7Ra in thymus and spleen was studied
using immunocytochemistry. Cortical thymocytes mainly repre-
sent double-positive cells expressing both CD4 and CD8. ChIL-7RaFig. 6. Immunocytochemical double-staining of chIL-7Ra (red) and T cell markers (blue) i
CD8a (panel 1), TCR-ab1 (panel 2, or TCR-gd (panel 3). A. Except for the outer cell layers ($
and CD8a. TCR-ab1+ cells co-expressed the chIL7Ra, whereas TCR-gd+ cells showed low
(triangle) of the spleen, some CD8a+ cells, most TCR-ab1+ cells and only few TCR-gdwas expressed onmost cortical thymocytes except for the outer 2–
5 cell layers in the subcapsular sinus, where the differentiation of
the precursor cells starts. These thymocytes do not express CD4 or
CD8. During migration from the cortex to the medulla, the
thymocytes mature into single-positive T cells [18]. In the medulla
most CD4+ and CD8+ cells co-expressed chIL-7Ra. Differences in
staining were found when cells were stained for TCR-gd and TCR-
ab1 (TCR1 and TCR2 respectively). Almost all ab1-TCR+ cells co-
expressed IL-7Ra in the medulla, but many TCR-gd+ cells did not
co-express chIL-7Ra (Fig. 6A). In the spleen, the FACS analysis
results were conﬁrmed.Many CD4+ cells but fewer CD8a+ cells co-
expressed chIL-7Ra, whereas most TCR-ab1+ cells also co-
expressed IL-7Ra (Fig. 6B). Few TCR-gd+ cells expressed the
chIL-7Ra (Fig. 6).
4. Discussion
Herein we describe the cloning, characterisation, and expres-
sion patterns of the chicken IL-7Ra. Like mammalian IL-7Ra, the
chIL-7Ra protein sequence contains a GXWSXWS motif located in
the FN_III domain. This motif is conserved among type I cytokine
receptor family members. Moreover, a small membrane proximal
domain termed ‘‘Box 1’’ (Val277 to His284) and an 11 aa motif
containing two tyrosine residues (Tyr450 and Tyr457) were also
conserved. All these features strongly suggested that the cDNA
described in this paper encodes the alpha chain of chIL-7R. The
estimated molecular mass of chIL-7Ra was 52.2 kDa.
The IL-7R consists of two components, the IL-7Ra and agc. Both
chains are essential for the biological effects of IL-7 [19], as
homodimerisation of chimeric IL-7Ra is not sufﬁcient for
signalling [20]. The model of IL-7R signalling is presumed to
resemble that of other gc family cytokines, with IL-2Rb being best
studied [21,22]. IL-7 ﬁrst binds to IL-7Ra and then recruits gc,
bringing together their intracellular domains bearing Jak1 and
Jak3. After mutual phosphorylation, these kinases acquire much
higher activity and phosphorylate the critical Y449 (as numbered
in the murine sequence) site on the IL-7Ra. This site binds STAT5
and possibly other adaptors and in turn becomes phosphorylated
by Jak1 and/or Jak3. Jiang et al. [23] showed that deletion of Box 1
eliminated Jak1 phosphorylation andmutation of Y449 eliminatedn cryosections of thymus (A) and spleen (B). Double-stainingwith anti-chIL-7Ra and
), most thymocytes in the cortex (C) and in themedulla (M) co-expressed chIL-7Ra
er levels of co-expression with chIL-7Ra. B. In the T cells areas around the arterioles
+ cells co-expressed chIL-7Ra.
D.A. van Haarlem et al. / Developmental and Comparative Immunology 33 (2009) 1018–1026 1025STAT5 phosphorylation. Both Box 1 and Y449 played a critical role
in generation of thymocytes in vivo [23]. The chIL-7Ra also
contains a Box 1 domain and a tyrosine-containing motif with two
tyrosines (Y450 and Y457) with conserved spacing between them
when compared to the samemotifs inmammalian and ﬁsh IL-7Ra.
Though not proven, based on the sequence homology of the IL-7Ra
it is likely that these signalling pathways will be conserved in the
chicken, especially as Jak1, Jak3 and STAT5 are all present in the
chicken genome.
In the chicken, IL-7Ra mRNA expression in primary and
secondary lymphoid organs of embryos increased during devel-
opment (data not shown) and at ED20 high mRNA expression
levels were seen, especially in lymphoid organs rich in T cells. In
splenic cell subpopulations, the highest mRNA expression levels
were seen in T cell subpopulations, in CD4+, CD8a+ and CD8b+
cells, which coincides with the expression pattern of the IL-7Ra in
mammals.
Subsequently, expression of the chIL-7Ra protein was investi-
gated on PBMC and splenocytes using a newly developed mono-
clonal antibody, 8F10E11. In blood, most CD4+ cells expressed chIL-
7Ra independent of the age of the birds. In contrast, the percentage
of CD8a+ cells expressing chIL-7Ra in blood decreased with
increasing age. On these cells chIL-7Ra was mostly expressed on
CD8aint cells. Interestingly, these cells rarely co-expressed CD8b,
indicating that although IL-7Ra mRNA was expressed in CD8b+
cells, the protein was not expressed on the surface of the cells.
Stimulation of splenocytes didnot induce expression of chIL-7Ra on
CD8b+ cells (datanot shown). Theﬁnding thatmRNA transcripts are
found in CD8b+ cells, but extracellular protein expression cannot be
detected, needs further investigation, which will be focussed on
intracellular expression of IL-7Ra and antigen-speciﬁc stimulation
ofCD8b+ cells. The expressionof chIL-7Raonsplenic CD4andCD8a
cells was comparable to PBMC, except for the percentage of positive
cells. A signiﬁcantly lower percentage of CD4+ and CD8a+ spleen
cells co-expressed the receptor,with no effect of age on the CD4+ IL-
7Ra+ cells and a decreasing percentage of CD8a+ IL-7Ra+ cells with
increasing age. In both peripheral blood and spleen there was no
preferential expression of chIL-7Ra on either TCR-ab1+ or TCR-
ab2+ cells. The lower percentage of chIL-7Ra+ T cells in the spleen
might indicate that a higherpercentage of T cells are activated in this
organ.
Levels of CD8a expression inversely correlated with expression
levels of IL-7Ra (Fig. 4B), in that CD8aint+ cells expressed chIL-7Ra
and most CD8ahi+ cells did not. The CD8aint+ cells mostly express
the CD8aa homodimer and not the CD8ab heterodimer.
Especially in blood, some of the CD8aint cells were CD4+ CD8aa+.
In chickens, CD8aa homodimers have to date been described on
NK cells [24] and intestinal intraepithelial lymphocytes [25]. In
mice, CD8aa is constitutively expressed on intraepithelial
lymphocytes [26], but not uniquely on mucosal T cells. CD8aa
is not expressed on resting naı¨ve T cells in the periphery, but co-
expression of CD8aa and CD8ab on activated conventional T cells
has been reported [27,28]. The induction of CD8aa on primary
effector cells in vivo is not an activationmarker, but CD8aa plays a
role during initial survival and differentiation of the memory
precursor. Consistent with memory precursors, these CD8aa+
cells co-expressed high levels of IL-7R, which is characteristic for
memory T cells and their predecessors [29,30]. Using cytotoxic T
cell lines, the expression of both CD8 isoforms was shown to be
differentially regulated. In response to TCR activation in vitro
CD8ab is down-regulated and internalised together with the
activated TCR, whereas CD8aa is up-regulated [30]. Although it is
unclear as to what occurs to CD8 isoforms upon TCR stimulation in
the chicken, the CD8aa+ cells in blood and spleen are relatively
more intracellular IFN-g+ than the CD8ahi+ population [13], which
could indicate that these cells have a memory or predecessorphenotype in the chicken too. Luhtala et al. [31] demonstrated that
chicken CD4+ CD8aa+ cells are functionally normal T cells, since
they proliferate in response to mitogens and signals delivered via
the TCR-ab as well as via the CD28 co-receptor.
In mammals, IL-7Ra transcription is suppressed in response
to IL-7, to other pro-survival cytokines (IL-2, IL-4, IL-6, and IL-
15) and upon antigen encounter. Consequently, IL-7R
expression is reduced and these T cells undergo massive clonal
proliferation and differentiation into effector cells, and do not
compete with unstimulated T cells for any remaining IL-7.
Chicken splenocytes were polyclonally stimulated with ConA
and the expression of chIL-7Ra decreased signiﬁcantly there-
after. Considering that the number of CD4+ and CD8a+ cells
increased after stimulation and the geometric MFI of CD4+ and
CD8a+ staining slightly decreased, the down-regulation of chIL-
7Ra cell surface expression was unlikely to be due to loss of
CD4+ and CD8a+ cells.
The immunocytochemical data conﬁrmed the chIL-7Ra expres-
sion patterns shown by FACS analysis, indicating that we developed
a useful tool to detect chicken IL-7Ra that can be applied in different
techniques, thereby expanding the chicken’s ‘‘immunological tool-
box’’. Future research will focus on chicken T cell development and
discrimination between functional T cell subsets.
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